Skip to content

Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit

Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit: a Sub-study of the Wireless NICU Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07732244
Enrollment
20
Registered
2026-07-28
Start date
2025-11-15
Completion date
2026-12-01
Last updated
2026-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysm Cerebral, Congenital Heart Disease, Hypoxic-Ischemic Encephalopathy, Stroke Hemorrhagic

Keywords

NIRS, Near-Infrared Spectroscopy, Wireless Sensor, Technology, NICU

Brief summary

The wireless NIRS sensor will be placed on the participant's forehead, directly underneath the INVOS wired sensor. The wireless NIRS sensor will remain in place for 4 consecutive hours, over 2 consecutive days. As standard-of-care, nursing personnel removes all sensors at every care to evaluate skin and reduce the risk of pressure sores. The wireless NIRS device will be removed and reapplied at the same time, by the research team who will annotate what time the sensor was removed, replaced, and the condition of the skin. This will be used to correlate signal disconnection with sensor care (i.e., skin checks, sensor removal, etc.).

Interventions

DEVICEWireless NIRS

Wireless NIRS applied to participant forehead.

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Infants admitted to the NICU with a gestational age of ≥ 32 weeks at the time of the monitoring * undergoing monitoring with the INVOS wired NIRS system.

Exclusion criteria

* Infants with a skin abnormality that would potentially increase the risk of injury, * Patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of rStO2, data between the wireless NIRS and gold-standard wired NIRS.6 monthsComparison of rStO2, data between the wireless NIRS and gold-standard wired NIRS.

Secondary

MeasureTime frameDescription
Comparison of SpO2 and Heart Rate (HR) data between the wireless NIRS and gold-standard wired vital sign monitoring system (Philips IntelliVue MX800).6 monthsComparison of SpO2 and Heart Rate (HR) data between the wireless NIRS and gold-standard wired vital sign monitoring system (Philips IntelliVue MX800).
Comparison of derived Heart Rate Variability (HRV) between the wireless NIRS and gold-standard wired vital sign monitoring system (Philips IntelliVue MX800).6 monthsComparison of derived Heart Rate Variability (HRV) between the wireless NIRS and gold-standard wired vital sign monitoring system (Philips IntelliVue MX800).
Provide a questionnaire to capture the perspectives of clinicians and patients' parents/guardians regarding use of the wireless NIRS compared to wired NIRS device.6 monthsProvide a a custom study questionnaire to capture the perspectives of clinicians and patients' parents/guardians regarding use of the wireless NIRS compared to wired NIRS device. The questionnaire includes Likert-scale items, multiple-choice questions, and open-ended responses evaluating usability, perceived safety, accuracy, comfort, and acceptability. Responses will be summarized descriptively by questionnaire item.

Countries

Canada

Contacts

CONTACTAlyssa Maximov, BSc
alyssa.maximov@muhc.mcgill.ca5149341934
PRINCIPAL_INVESTIGATORGuilherme Sant'Anna, MD, PhD

RI-MUHC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 29, 2026